1-7 of 7
Anna Linke
Close
Sort by
Journal Articles

Activity of Anti-Tumor Endoribonucleases, Onconase (ranpirnase) and R-Amphinase in Chronic Lymphocytic Leukemia

Piotr Smolewski, Anna Linke-Szewczyk, Barbara Cebula, Kuslima Shogen, Wojciech Ardelt, Zbigniew Darzynkiewicz, Tadeusz Robak, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4205.
https://doi.org/10.1182/blood.V112.11.4205.4205
Published: 2008
Journal Articles

Ex Vivo Cytotoxic Activity of Endoribonucleases, Onconase (ranpirnase) and R-Amphinase, against Acute Myeloblastic Leukemia Cells

Piotr Smolewski, Barbara Cebula, Malgorzata Zwolinska, Anna Linke-Szewczyk, Dominika Wozniak, Kuslima Shogen, Wojciech Ardelt, Zbigniew Darzynkiewicz, Tadeusz Robak, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4010.
https://doi.org/10.1182/blood.V112.11.4010.4010
Published: 2008
Journal Articles

Cytotoxic Effect of R-Etodolac (SDX-101) in Combination with Purine Analogues or Monoclonal Antibodies on Ex-Vivo B-Cell Chronic Lymphocytic Leukemia Cells.

Pawel Robak, Anna Linke, Barbara Cebula, Lorenzo M. Leoni, Tadeusz Robak, Piotr Smolewski
Journal: Blood
Blood (2005) 106 (11): 2122.
https://doi.org/10.1182/blood.V106.11.2122.2122
Published: 2005
Journal Articles

Anti-CD20 and Anti-CD52 Monoclonal Antibodies Enhance Cytotoxicity of Bortezomib Against Chronic Lymphocytic Leukemia Cells.

Piotr Smolewski, MD, PhD, Markus Duechler, PhD, Anna Linke, Barbara Cebula, Olga Grzybowska-Izydorczyk, MD, Medhat Shehata, MD, PhD, Tadeusz Robak, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2972.
https://doi.org/10.1182/blood.V106.11.2972.2972
Published: 2005
Journal Articles

Inhibition of mTOR Kinase Pathway Selectively Sensitizes Acute Myeloid Leukemia Cells to Cytarabine-Induced Apoptosis.

Piotr Smolewski, Agnieszka Janus, Barbara Cebula, Anna Linke, Krzysztof Jamroziak, Tadeusz Robak
Journal: Blood
Blood (2005) 106 (11): 2474.
https://doi.org/10.1182/blood.V106.11.2474.2474
Published: 2005
Journal Articles

Cytotoxic Effect of Proteasome Inhibitor Bortezomib in Combination with Purine Nucleoside Analogues on Chronic Lymphocytic Leukemia Cells in Vitro.

Piotr Smolewski, Markus Duechler, Anna Linke, Barbara Cebula, Josef D. Schwarzmeier, Tadeusz Robak
Journal: Blood
Blood (2004) 104 (11): 4822.
https://doi.org/10.1182/blood.V104.11.4822.4822
Published: 2004
Journal Articles

Rapamycin, Inhibitor of Mtor Kinase, Sensitizes Leukemia Cells to Fludarabine-Induced Apoptosis, but Protects Survival of Normal Lymphocytes.

Piotr Smolewski, Barbara Cebula, Dorota Wierzbicka, Anna Linke, Krzysztof Jamroziak, Mikhail V. Blagosklonny, Zbigniew Darzynkiewicz, Tadeusz Robak
Journal: Blood
Blood (2004) 104 (11): 4497.
https://doi.org/10.1182/blood.V104.11.4497.4497
Published: 2004